Publication | Closed Access

The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study

Non-pharmacological InterventionHypertensionCardiovascular DiseaseHigh Blood PressureAntihypertensive TherapyPharmacologyCardiovascular PharmacologySafety StudyBlood Pressure ControlOlmesartan MedoxomilPharmacotherapyMedicineBlood Pressure